The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro.
Anna GidariSamuele SabbatiniElisabetta SchiaroliSabrina BastianelliSara PierucciChiara BustiLucia ComezValeria LiberaAntonio MacchiaruloAlessandro PaciaroniIlaria VicentiMaurizio ZazziDaniela FrancisciPublished in: Microorganisms (2022)
Molnupiravir associated with one of the two protease-inhibitors nirmatrelvir and GC376 showed good additive-synergic activity in vitro.